RxSight, Inc.RXSTNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +40.71% | +28.41% | -3.58% | -33.18% | -18.92% |
| Gross Profit Growth | +63.07% | +36.95% | +3.88% | -3.94% | -12.24% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +12.22% | +9.95% | +5.95% | +2.96% | +2.03% |
| Weighted Average Shares Diluted Growth | +12.22% | +9.95% | +5.95% | +2.96% | +2.03% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | -262.60% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +48.17% | +43.66% | +9.08% | -4.80% | -22.19% |
| Inventory Growth | +26.34% | +26.06% | +28.89% | +33.58% | +43.39% |
| Asset Growth | +74.51% | +70.91% | +1.15% | -0.62% | -2.12% |
| Book Value per Share Growth | +56.28% | +54.97% | -4.65% | -3.32% | -3.92% |
| Debt Growth | +308.23% | +377.48% | +2.67% | +2.31% | -10.21% |
| R&D Expense Growth | +25.42% | +29.09% | +23.23% | +2.51% | -3.28% |
| SG&A Expenses Growth | +33.28% | +22.77% | +19.28% | +6.78% | -1.83% |